| 30563098
|
Recent Advances in Oncolytic Virotherapy and Immunotherapy for Glioblastoma: A Glimmer of Hope in the Search for an Effective Therapy? |
Cancers (Basel) |
2018 |
Stepanenko AA;Chekhonin VP |
View
More |
| 33875611
|
Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma. |
J Immunother Cancer |
2021 |
Beasley GM;Nair SK;Farrow NE;Landa K;Selim MA;Wiggs CA;Jung SH;Bigner DD;True Kelly A;Gromeier M;Salama AK |
View
More |
| 34503272
|
Prior Exposure to Coxsackievirus A21 Does Not Mitigate Oncolytic Therapeutic Efficacy. |
Cancers (Basel) |
2021 |
Burnett WJ;Burnett DM;Parkman G;Ramstead A;Contreras N;Gravley W;Holmen SL;Williams MA;VanBrocklin MW |
View
More |
| 35674873
|
Oncolytic Viral Therapy for Malignant Glioma and Their Application in Clinical Practice. |
Neurotherapeutics |
2022 |
Shoaf ML;Desjardins A |
View
More |
| 37313455
|
Trap and ambush therapy using sequential primary and tumor escape-selective oncolytic viruses. |
Mol Ther Oncolytics |
2023 |
Webb MJ;Kottke T;Kendall BL;Swanson J;Uzendu C;Tonne J;Thompson J;Metko M;Moore M;Borad M;Roberts L;Diaz RM;Olin M;Borgatti A;Vile R |
View
More |
